SAFEbuilt, one of the nation's most trusted community development services partners, announced the continued expansion of its growing lineup of webinars and thought leadership content designed to help ...
Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for applications across infectious disease, immunology, and other therapeutic areas, and ...
The US FDA has cleared the first updates to the algorithm of the Omnipod 5 automated insulin delivery (AID) system (Insulet ...
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced it has received FDA 510(k) ...
The FDA cleared an updated algorithm for a hybrid closed-loop insulin delivery system that permits users to set a lower ...
Medical Device Network on MSN
FDA clears Insulet’s Omnipod 5 algorithm enhancements
Insulet anticipates that the Omnipod 5 algorithm update will launch in the US in H1 2026. The company highlighted that the new insulin target range aims to allow healthcare providers to tailor insulin ...
Zacks Investment Research on MSN
PODD stock benefits from FDA approval of Omnipod 5's enhancements
Insulet Corporation PODD recently received FDA 510(k) clearance for significant enhancements to the Omnipod 5 Automated Insulin Delivery System. These updates to the Omnipod 5 algorithm set a new ...
Submission delayed by U.S. government shutdown; initial FDA questions expected during Q4 2025 "The Pivot submission is an exciting milestone in our mission to deliver a differentiated tubeless patch ...
It was not long until Ms Pantelis, who was 10 years old at the time, was diagnosed with the same life-altering auto-immune condition as her younger sister Georgia. “I was really annoyed that it got me ...
In the past couple of years, an onslaught of new wearable breast pumps have been brought to market. The Eufy Wearable Breast Pump S1 Pro is one of these new models, but it manages to stand out from ...
Insulet (Nasdaq:PODD) announced today that it received FDA 510(k) clearance for new enhancements to its Omnipod 5 system.
Insulet (Nasdaq:PODD) today announced immediate compatibility between its Omnipod 5 system and the Dexcom (Nasdaq:DXCM) G7 15 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback